Pan-Malaria Transmission-Blocking Vaccine AnAPN1
Clinical trial NCT05905432 · COMPLETED
Trial details
- NCT number
- NCT05905432
- Sponsor
- Centre de Recherche Médicale de Lambaréné
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2025-01-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.